BJDX insider trading
NasdaqCM HealthcareBluejay Diagnostics, Inc.: insider trade history from SEC Form 4 filings.
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well as other tests using the Symphony platform. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
Company website: bluejaydx.com
BJDX insider activity at a glance
FilingIQ tracks 34 insider transactions for BJDX in filings since Mar 16, 2022. The most recent transaction is dated Aug 17, 2026.
Across the full history, 20 open-market purchases
and 1 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
How FilingIQ classifies each line, and the seven facts it shows on every open-market purchase and sale, are documented on the methodology page.
Latest BJDX Form 4 filings
Most recent disclosures. Sign up to filter by transaction code, insider role or dollar value.
Other Healthcare tickers with recent insider activity
Most active insiders at BJDX
By number of Form 4 lines in the last 180 days.
Frequently asked
- How many insider trades does FilingIQ track for BJDX?
- FilingIQ tracks 34 Form 4 insider transactions for BJDX (Bluejay Diagnostics, Inc.), covering filings from Mar 16, 2022 onwards. 1 of those are dated within the last 90 days.
- Are BJDX insiders net buyers or net sellers?
- Across the full Form 4 history for BJDX, 20 transactions (59%) were open-market purchases and 1 (3%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BJDX insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ links every filing to the insider's SEC CIK, marks plan trades, tax withholding, option exercises, gifts, derivatives and amendments, and shows each open-market purchase and sale with the same fixed facts. It does not rate the stock.
- What sector is BJDX in?
- Bluejay Diagnostics, Inc. (BJDX) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $3.99M.
Methodology & sources
Every BJDX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). How lines are classified and which facts FilingIQ adds is documented on the methodology page; the people behind it are on the team page. Not investment advice; see disclaimer.